{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:41:41Z","timestamp":1784324501840,"version":"3.55.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Abdominal sepsis is a critical and high-risk condition in intensive care, characterized by diagnostic challenges, complex treatment, and high mortality. Non-specific symptoms and the difficulty of discriminating harmful bacteria from the normal flora complicate a timely diagnosis and treatment. Although timely interventions are crucial, the best timing of surgery remains uncertain, especially in unstable patients. Diagnostic markers like C-reactive protein, procalcitonin, and interleukins help guide diagnosis but often lack specificity of an abdominal focus. This study aims to identify possible additional markers for earlier detection of abdominal sepsis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Plasma samples were collected from 47 sepsis patients at the day of sepsis diagnosis, and from 10 healthy controls. Patients were retrospectively categorized into those with abdominal (n=23) and those with non-abdominal (n=24) sepsis. Patient`s characteristics, clinical outcomes, physiological and laboratory parameters, and cytokine levels were assessed. Receiver operating characteristic curves and Spearman correlation analyses were conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Age and sex proportions were comparable across the sepsis groups, as were the chronic disease prevalence, the severity of illness and mortality rates. Patients with abdominal sepsis were more likely to undergo emergency surgeries. Pro-inflammatory cytokines like IL-6, MCP-1, and IL-18 were elevated, as was the anti-inflammatory IL-10 in both sepsis cohorts compared to healthy controls. IL-18 was particularly associated with a more severe inflammatory response in non-abdominal sepsis. IL-18 levels below 1892.00 pg\/mL showed 82.6% sensitivity and 56.5% specificity for identifying patients with abdominal sepsis, with a significant diagnostic accuracy (AUC 0.68, p = 0.034). This suggests IL-18 as a useful additional moderate predictor for critical cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results demonstrate that IL-18, IL-6, MCP-1, and IL-10 are increased in sepsis, while IL-18 may serve as an additional biomarker for distinguishing abdominal from non-abdominal sepsis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1591262","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:25:47Z","timestamp":1748496347000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Diagnostic utility of IL-18 plasma levels in distinguishing abdominal from non-abdominal sepsis"],"prefix":"10.3389","volume":"16","author":[{"given":"Anna","family":"Herminghaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mykola","family":"Totskyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dimski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Brandenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kuebart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Rinderknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian B.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Vernikouskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin Maria","family":"B\u00fclow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borna","family":"Relja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019\u2014 results from a systematic review and meta-analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05819-3","article-title":"Epidemiology of intra-abdominal infection and sepsis in critically ill patients: \u201cAbSeS\u201d, a multinational observational cohort study and ESICM Trials Group Project","volume":"45","author":"Blot","year":"2019","journal-title":"Intensive Care Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-016-4307-6","article-title":"Therapeutic management of peritonitis: a comprehensive guide for intensivists","volume":"42","author":"Montravers","year":"2016","journal-title":"Intensive Care Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565120-00002","article-title":"Critical issues in the clinical management of complicated intra-abdominal infections","volume":"65","author":"Blot","year":"2005","journal-title":"Drugs"},{"key":"B5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamasurg.2022.2761","article-title":"Association between time to source control in sepsis and 90-day mortality","volume":"157","author":"Reitz","year":"2022","journal-title":"JAMA Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/cc13854","article-title":"Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock","volume":"18","author":"Azuhata","year":"2014","journal-title":"Crit Care"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06883-y","article-title":"Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis","volume":"48","author":"De Pascale","year":"2022","journal-title":"Intensive Care Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2014.166","article-title":"Inadequate source control and inappropriate antibiotics are key determinants of mortality in patients with intra-abdominal sepsis and associated bacteremia","volume":"16","author":"Tellor","year":"2015","journal-title":"Surg Infections"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/sur.2016.261","article-title":"The surgical infection society revised guidelines on the management of intra-abdominal infection","volume":"18","author":"Mazuski","year":"2017","journal-title":"Surg Infections"},{"key":"B10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13054-023-04507-5","article-title":"Time to treatment and mortality for clinical sepsis subtypes","volume":"27","author":"Yang","year":"2023","journal-title":"Crit Care"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002011","article-title":"Impact of source control in patients with severe sepsis and septic shock","volume":"45","author":"Mart\u00ednez","year":"2017","journal-title":"Crit Care Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2024.01.002","article-title":"Importance of timely and adequate source control in sepsis and septic shock","volume":"4","author":"De Waele","year":"2024","journal-title":"J Intensive Medicine"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2478\/jccm-2018-0023","article-title":"Abdominal sepsis: an update","volume":"4","author":"Mure\u0219an","year":"2018","journal-title":"J Crit Care Medicine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.915435","article-title":"Predictors of 30-day in-hospital mortality in patients undergoing urgent abdominal surgery due to acute peritonitis complicated with sepsis","volume":"25","author":"Ma\u010diulien\u0117","year":"2019","journal-title":"Med Sci Monit"},{"key":"B16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13017-017-0141-6","article-title":"The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections","volume":"12","author":"Sartelli","year":"2017","journal-title":"World J Emerg Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2013.02.021","article-title":"The challenge of intra-abdominal sepsis","volume":"11","author":"Weledji","year":"2013","journal-title":"Int J Surgery"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2017.05.014","article-title":"Evaluation of lactate, white blood cell count, neutrophil count, procalcitonin and immature granulocyte count as biomarkers for sepsis in emergency department patients","volume":"50","author":"Karon","year":"2017","journal-title":"Clin Biochem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2017.08.024","article-title":"Revisiting the prognostic value of monocyte chemotactic protein 1 and interleukin-6 in the sepsis-3 era","volume":"43","author":"Barre","year":"2018","journal-title":"J Crit Care"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.04.003","article-title":"Interleukin-18 serum levels in sepsis: Correlation with disease severity and inflammatory markers","volume":"120","author":"Mierzchala-Pasierb","year":"2019","journal-title":"Cytokine"},{"key":"B21","article-title":"IL\u221218 and IL\u221235 in the serum of patients with sepsis thrombocytopenia and the clinical significance","volume":"19","author":"Zhu","year":"2019","journal-title":"Exp Ther Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/imr.2018.281.issue-1","article-title":"Interleukin-18: Biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunological Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.10.072","article-title":"Epithelial IL-18 equilibrium controls barrier function in colitis","volume":"163","author":"Nowarski","year":"2015","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.03.003","article-title":"The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis","volume":"32","author":"Zaki","year":"2010","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/1471-2334-14-420","article-title":"Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome","volume":"14","author":"De Waele","year":"2014","journal-title":"BMC Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2010.02705.x","article-title":"Multiplex cytokine profiling in patients with sepsis","volume":"119","author":"Mera","year":"2011","journal-title":"APMIS"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.241.139","article-title":"Plasma monocyte chemoattractant protein 1 as a predictive marker for sepsis prognosis: A prospective cohort study","volume":"241","author":"Zhu","year":"2017","journal-title":"Tohoku J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"109130","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int Immunopharmacology"},{"key":"B31","article-title":"Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis","volume":"8","author":"Hou","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1556\/1646.2020.00006","article-title":"Plasma interleukin-6 levels correlate with survival in patients with bacterial sepsis and septic shock","volume":"11","author":"Vivas","year":"2021","journal-title":"IMAS"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-200116060-00001","article-title":"INTERLEUKIN-18 PLASMA LEVELS ARE INCREASED IN PATIENTS WITH SEPSIS COMPARED TO SEVERELY INJURED PATIENTS","volume":"16","author":"Oberholzer","year":"2001","journal-title":"Shock"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1515793113","article-title":"Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18","volume":"113","author":"Wynn","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1535OC","article-title":"Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock","volume":"189","author":"Berghe","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2292ED","article-title":"Dual inhibition of interleukin-1\u03b2 and interleukin-18: A new treatment option for sepsis","volume":"189","author":"Opal","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S393506","article-title":"Clinical value of serum interleukin-18 in neonatal sepsis diagnosis and mortality prediction","volume":"15","author":"Li","year":"2022","journal-title":"JIR"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12971","article-title":"Inflammasome gene profile is modulated in septic patients, with a greater magnitude in non-survivors","volume":"189","author":"Esquerdo","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.12.009","article-title":"Biochemical and inflammatory aspects in patients with severe sepsis and septic shock: The predictive role of IL-18 in mortality","volume":"453","author":"Eidt","year":"2016","journal-title":"Clinica Chimica Acta"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment","volume":"13","author":"Ihim","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1591262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:25:48Z","timestamp":1748496348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1591262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2025.1591262"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1591262","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"article-number":"1591262"}}